FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.
The historical rank and industry rank for Syngene International's FCF Yield % or its related term are showing as below:
NSE:SYNGENE'
s FCF Yield % Range Over the Past 10 Years
Min: 0 Med: 0 Max: 3.28
Current: 3.24
During the past 13 years, the highest FCF Yield % of Syngene International was 3.28%. The lowest was 0.00%. And the median was 0.00%.
NSE:SYNGENE's FCF Yield % is ranked better than 72.43% of 214
companies
in the Medical Diagnostics & Research industry
Industry Median: -1.365
vs NSE:SYNGENE: 3.24
Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Syngene International FCF Yield % Related Terms
Syngene International FCF Yield % Historical Data
* Premium members only.
The historical data trend for Syngene International's FCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:SYNGENE vs TMO, DHR, IDXX: FCF Yield % Comparison
For the Diagnostics & Research subindustry, Syngene International's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Syngene International FCF Yield % vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Syngene International's FCF Yield % distribution charts can be found below:
* The bar in red indicates where Syngene International's FCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Syngene International (NSE:SYNGENE) has a FCF Yield % of 3.24 as of Jul. 11, 2026. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Syngene International and its competitors. According to the industry distribution chart, Syngene International ranks #59 out of 214 companies in the Medical Diagnostics & Research industry, placing it in the top 27.6%.
Is Syngene International's FCF Yield % too high?
Syngene International's current FCF Yield % is 3.24. Based on the distribution chart, Syngene International ranks #59 out of 214 companies in the Medical Diagnostics & Research industry, which is above the industry midpoint. Overall, Syngene International has a GF Score™ of 79/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Syngene International's FCF Yield % compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Syngene International ranks #59 out of 214 companies for FCF Yield %. This puts Syngene International in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Yield % for a Medical Diagnostics & Research company?
A good FCF Yield % depends on the Medical Diagnostics & Research industry context. However, FCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Yield % mean?
A high FCF Yield % can signal that a stock is expensive relative to its fundamentals. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Syngene International and its competitors. Syngene International's current FCF Yield % is 3.24. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Syngene International stock overvalued right now?
Based on GuruFocus' analysis, Syngene International (NSE:SYNGENE) is currently considered Significantly Undervalued. The stock's GF Value™ is ₹768.64, compared to a current price of ₹420.35 — trading 45.3% below its estimated fair value. The current FCF Yield % is 3.24. Syngene International's overall GF Score™ is 79/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Yield % calculated?
FCF Yield % is calculated from a company's financial statements. For Syngene International (NSE:SYNGENE), the current FCF Yield % is 3.24 as of Jul. 11, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Syngene International (NSE:SYNGENE) Overvalued in 2026?
Based on GuruFocus' analysis, Syngene International stock appears to be undervalued.
The current stock price of ₹420.35 is trading 45.3% below its estimated GF Value™ of ₹768.64.
GuruFocus considers Syngene International to be Significantly Undervalued.
Key valuation signals for NSE:SYNGENE:
FCF Yield %: 3.24
GF Value™: ₹768.64 vs. price of ₹420.35 (45.3% below fair value)
No single metric tells the full story. See the NSE:SYNGENE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Syngene International Ltd is a contract research and manufacturing organization in India. It supports research and development programs, from lead generation to clinical and commercial supplies. The Company is engaged in a single operating segment of providing contract research and manufacturing services. The company operates in India, the United States of America and other countries, of which a majority of the revenue is derived from the USA. The company receives revenue by providing contract research and manufacturing services. It offers services such as Oligonucleotide synthesis, Bioinformatics, Clinical development services, polymer research, chemical development, safety assessment, discovery chemistry, discovery biology, and others.
79GF Score
Get the complete analysis for NSE:SYNGENE
FCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:SYNGENE has been successfully added to your 
